Taken together, all the results demonstrated that TAZ was a crucial downstream effector of HDAC9 and HDAC9 promoted cell proliferation and tumor formation via TAZ-mediated EGFR activation in GBM Figure 8. The gene discussed is EGFR; the disease is glioblastoma.